F
Forte Biosciences, Inc.
FBRX · NASDAQ · Healthcare · 1.6B
Price · close
$76.92
+0.04% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
18.6×
Enterprise value / EBITDAEV/EBITDA
-15.5×
Free cash flow yieldFCF yield
-4.5%
Return on equityROE
-113.7%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.